Sources of racial/ethnic differences in awareness of HIV vaccine trials
Michael P Arnold1, Michele Andrasik, Stewart Landers
1Michael P. Arnold, Michele Andrasik, Shelly Karuna, and Steven Wakefield are with the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Stewart Landers is with Boston Health Services, John Snow Inc., Boston, MA. Matthew J. Mimiaga is with the Department of Epidemiology, Harvard School of Public Health, Cambridge, MA. Kenneth Mayer is with the Department of Global Health and Population, Harvard School of Public Health. Susan Buchbinder is with Bridge HIV, San Francisco Department of Public Health, San Francisco, CA. Beryl A. Koblin is with Project Achieve, New York Blood Center, New York, NY.
Objectives:
We explored the relative effects of 2 awareness components-exposure and attention-on racial/ethnic differences in HIV vaccine trial awareness among men who have sex with men (MSM).
Methods:
Surveys assessing awareness of and attitudes toward HIV vaccine trials were administered to 1723 MSM in 6 US cities. Proxy measures of exposure included use of HIV resources and other health care services, community involvement, income, and residence. Attention proxy measures included research attitudes, HIV susceptibility, and HIV message fatigue. Using logistic regression models, we assessed the extent to which these proxies accounted for racial/ethnic differences in vaccine trial awareness.
Results:
White MSM reported significantly (P < .01) higher rates of HIV vaccine trial awareness (22%) compared with Latino (17%), Black (13%) and "other" (13%) MSM. Venue-based exposure proxies and research-directed attitudinal attention proxies were significantly associated with awareness, but only accounted for the White-Latino disparity in awareness. No proxies accounted for the White-Black or White-"other" differentials in awareness.
Conclusions:
Sources of disparities in awareness of HIV vaccine trials remain to be explained. Future trials seeking to promote diverse participation should explore additional exposure and attention mediators.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Related Concept Videos
Surveys
Bias in Epidemiological Studies
Stereotypes, Prejudice, and Discrimination
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Blinding
Clinical Trials: Overview
